Literature DB >> 29463708

Environmental enrichment and exercise are better than social enrichment to reduce memory deficits in amyloid beta neurotoxicity.

Mariza G Prado Lima1, Helen L Schimidt2, Alexandre Garcia1, Letícia R Daré1, Felipe P Carpes2, Ivan Izquierdo3, Pâmela B Mello-Carpes4.   

Abstract

Recently, nongenetic animal models to study the onset and development of Alzheimer's disease (AD) have appeared, such as the intrahippocampal infusion of peptides present in Alzheimer amyloid plaques [i.e., amyloid-β (Aβ)]. Nonpharmacological approaches to AD treatment also have been advanced recently, which involve combinations of behavioral interventions whose specific effects are often difficult to determine. Here we isolate the neuroprotective effects of three of these interventions-environmental enrichment (EE), anaerobic physical exercise (AnPE), and social enrichment (SE)-on Aβ-induced oxidative stress and on impairments in learning and memory induced by Aβ. Wistar rats were submitted to 8 wk of EE, AnPE, or SE, followed by Aβ infusion in the dorsal hippocampus. Short-term memory (STM) and long-term memory (LTM) of object recognition (OR) and social recognition (SR) were evaluated. Biochemical assays determined hippocampal oxidative status: reactive oxygen species, lipid peroxidation by thiobarbituric acid reactive substance (TBARS) test, and total antioxidant capacity by ferric reducing/antioxidant power (FRAP), as well as acetylcholinesterase activity. Aβ infusion resulted in memory deficits and hippocampal oxidative damage. EE and AnPE prevented all memory deficits (STM and LTM of OR and SR) and lipid peroxidation (i.e., TBARS). SE prevented only the SR memory deficits and the decrease of total antioxidant capacity decrease (i.e., FRAP). Traditionally, findings obtained with EE protocols do not allow discrimination of the roles of the three individual factors involved. Here we demonstrate that EE and physical exercise have better neuroprotective effects than SE in memory deficits related to Aβ neurotoxicity in the AD model tested.

Entities:  

Keywords:  Alzheimer’s disease; anaerobic physical exercise; object recognition; oxidative stress; social recognition

Mesh:

Substances:

Year:  2018        PMID: 29463708      PMCID: PMC5877978          DOI: 10.1073/pnas.1718435115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

1.  In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

Authors:  S Delobette; A Privat; T Maurice
Journal:  Eur J Pharmacol       Date:  1997-01-14       Impact factor: 4.432

Review 2.  Conformations and biological activities of amyloid beta peptide 25-35.

Authors:  L Millucci; L Ghezzi; G Bernardini; A Santucci
Journal:  Curr Protein Pept Sci       Date:  2010-02       Impact factor: 3.272

3.  Amyloid β-peptide 25-35 self-assembly and its inhibition: a model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer's disease process and treatment.

Authors:  Marina Naldi; Jessica Fiori; Marco Pistolozzi; Alex F Drake; Carlo Bertucci; Rongliang Wu; Krzysztof Mlynarczyk; Slawomir Filipek; Angela De Simone; Vincenza Andrisano
Journal:  ACS Chem Neurosci       Date:  2012-09-04       Impact factor: 4.418

4.  Environmental enrichment and isolation rearing in the rat: effects on locomotor behavior and startle response plasticity.

Authors:  G B Varty; M P Paulus; D L Braff; M A Geyer
Journal:  Biol Psychiatry       Date:  2000-05-15       Impact factor: 13.382

5.  A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data.

Authors:  A Ennaceur; J Delacour
Journal:  Behav Brain Res       Date:  1988-11-01       Impact factor: 3.332

Review 6.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

7.  Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits.

Authors:  A Stéphan; S Laroche; S Davis
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 8.  Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives.

Authors:  Maria Cristina Polidori; Gereon Nelles
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 9.  An active and socially integrated lifestyle in late life might protect against dementia.

Authors:  Laura Fratiglioni; Stephanie Paillard-Borg; Bengt Winblad
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

10.  Assessment of social interaction behaviors.

Authors:  Oksana Kaidanovich-Beilin; Tatiana Lipina; Igor Vukobradovic; John Roder; James R Woodgett
Journal:  J Vis Exp       Date:  2011-02-25       Impact factor: 1.355

View more
  21 in total

Review 1.  Therapeutic efficacy of environmental enrichment for substance use disorders.

Authors:  Ewa Galaj; Eddy D Barrera; Robert Ranaldi
Journal:  Pharmacol Biochem Behav       Date:  2019-11-26       Impact factor: 3.533

Review 2.  Microglia, Lifestyle Stress, and Neurodegeneration.

Authors:  Charlotte Madore; Zhuoran Yin; Jeffrey Leibowitz; Oleg Butovsky
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

3.  Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice.

Authors:  Martina Stazi; Silvia Zampar; Madeleine Nadolny; Luca Büschgens; Thomas Meyer; Oliver Wirths
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-06-09       Impact factor: 5.270

4.  Effects of Involuntary and Voluntary Exercise in Combination with Acousto-Optic Stimulation on Adult Neurogenesis in an Alzheimer's Mouse Model.

Authors:  Wan-Yi Li; Jun-Yan Gao; Su-Yang Lin; Shao-Tao Pan; Biao Xiao; Yu-Tao Ma; Kai Xie; Wei Shen; Zhi-Tao Liu; Guang-Yu Li; Jie-Jie Guo; Qin-Wen Wang; Li-Ping Li
Journal:  Mol Neurobiol       Date:  2022-03-17       Impact factor: 5.590

Review 5.  Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.

Authors:  Erin John Rieger de Almeida; Hélio Jungkenn Ibrahim; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Andréia Machado Cardoso
Journal:  Neurochem Res       Date:  2022-08-13       Impact factor: 4.414

6.  Mechanisms Associated with Type 2 Diabetes as a Risk Factor for Alzheimer-Related Pathology.

Authors:  Men Su; Kambiz Naderi; Nathalie Samson; Ihsen Youssef; Livia Fülöp; Zsolt Bozso; Serge Laroche; Benoit Delatour; Sabrina Davis
Journal:  Mol Neurobiol       Date:  2019-01-25       Impact factor: 5.590

7.  Environmental enrichment prevents Aβ oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.

Authors:  Zhiyun Wei; Xingjun Meng; Rachid El Fatimy; Bowen Sun; Dongmei Mai; Junfang Zhang; Ramil Arora; Ailiang Zeng; Pingyi Xu; Shaogang Qu; Anna M Krichevsky; Dennis J Selkoe; Shaomin Li
Journal:  Neurobiol Dis       Date:  2019-10-24       Impact factor: 5.996

Review 8.  Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging.

Authors:  Michael R Duggan; Vinay Parikh
Journal:  Behav Brain Res       Date:  2021-02-25       Impact factor: 3.332

9.  Is Environmental Enrichment Ready for Clinical Application in Human Post-stroke Rehabilitation?

Authors:  Matthew W McDonald; Kathryn S Hayward; Ingrid C M Rosbergen; Matthew S Jeffers; Dale Corbett
Journal:  Front Behav Neurosci       Date:  2018-07-11       Impact factor: 3.558

Review 10.  Perioperative Neurocognitive Disorder: State of the Preclinical Science.

Authors:  Roderic G Eckenhoff; Mervyn Maze; Zhongcong Xie; Deborah J Culley; Sarah J Goodlin; Zhiyi Zuo; Huafeng Wei; Robert A Whittington; Niccolò Terrando; Beverley A Orser; Maryellen F Eckenhoff
Journal:  Anesthesiology       Date:  2020-01       Impact factor: 8.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.